Adalimumab-ryvk Kit
Product Images NDC 51759-360

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Adalimumab-ryvk (NDC 51759-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Avt02 Unbranded 1)

1 (Avt02 Unbranded 1)
FDA Label Image

1 (Avt02 Unbranded 10)

1 (Avt02 Unbranded 10)
FDA Label Image

1 (Avt02 Unbranded 11)

1 (Avt02 Unbranded 11)
FDA Label Image

1 (Avt02 Unbranded 12)

1 (Avt02 Unbranded 12)
FDA Label Image

Figure H (Avt02 Unbranded 13)

Figure H (Avt02 Unbranded 13)
FDA Label Image

Figure I (Avt02 Unbranded 14)

Figure I (Avt02 Unbranded 14)
FDA Label Image

Figure J (Avt02 Unbranded 15)

Figure J (Avt02 Unbranded 15)
FDA Label Image

Figure K & Figure L (Avt02 Unbranded 16)

Figure K & Figure L (Avt02 Unbranded 16)
FDA Label Image

Figure M (Avt02 Unbranded 17)

Figure M (Avt02 Unbranded 17)
FDA Label Image

Figure N (Avt02 Unbranded 18)

Figure N (Avt02 Unbranded 18)
FDA Label Image

1 (Avt02 Unbranded 19)

1 (Avt02 Unbranded 19)
FDA Label Image

1 (Avt02 Unbranded 2)

1 (Avt02 Unbranded 2)
This text contains data regarding the ASAS 20 response comparing a placebo group with an adalimumab group over a period of weeks. The data includes the number of participants in each group (107 for placebo and 208 for adalimumab) and the time points measured in weeks. The ASAS 20 response is likely being evaluated for the effectiveness of adalimumab treatment.*
FDA Label Image

80 mg Ai (Avt02 Unbranded 20)

80 mg Ai (Avt02 Unbranded 20)
This text appears to describe a product or an object that may involve an inspection process on a gray body with orange components. It includes a "Needle" feature and mentions a "Window Grip Area" along with a "Sleeve." The details suggest that this text could be related to the specifications or components of a device, tool, or mechanical part.*
FDA Label Image

1 (Avt02 Unbranded 21)

1 (Avt02 Unbranded 21)
FDA Label Image

1 (Avt02 Unbranded 22)

1 (Avt02 Unbranded 22)
FDA Label Image

Figure C (Avt02 Unbranded 23)

Figure C (Avt02 Unbranded 23)
FDA Label Image

Figure D (Avt02 Unbranded 24)

Figure D (Avt02 Unbranded 24)
FDA Label Image

1 (Avt02 Unbranded 25)

1 (Avt02 Unbranded 25)
FDA Label Image

1 (Avt02 Unbranded 26)

1 (Avt02 Unbranded 26)
FDA Label Image

1 (Avt02 Unbranded 27)

1 (Avt02 Unbranded 27)
FDA Label Image

Figure H (Avt02 Unbranded 28)

Figure H (Avt02 Unbranded 28)
FDA Label Image

Figure I (Avt02 Unbranded 29)

Figure I (Avt02 Unbranded 29)
FDA Label Image

1 (Avt02 Unbranded 3)

1 (Avt02 Unbranded 3)
FDA Label Image

Figure J (Avt02 Unbranded 30)

Figure J (Avt02 Unbranded 30)
FDA Label Image

Figures K & L (Avt02 Unbranded 31)

Figures K & L (Avt02 Unbranded 31)
FDA Label Image

Figure M (Avt02 Unbranded 32)

Figure M (Avt02 Unbranded 32)
FDA Label Image

Figure N (Avt02 Unbranded 33)

Figure N (Avt02 Unbranded 33)
FDA Label Image

1 (Avt02 Unbranded 34)

1 (Avt02 Unbranded 34)
FDA Label Image

Parts Pfs (Avt02 Unbranded 35)

Parts Pfs (Avt02 Unbranded 35)
FDA Label Image

A (Avt02 Unbranded 36)

A (Avt02 Unbranded 36)
FDA Label Image

B (Avt02 Unbranded 37)

B (Avt02 Unbranded 37)
FDA Label Image

C (Avt02 Unbranded 38)

C (Avt02 Unbranded 38)
FDA Label Image

D (Avt02 Unbranded 39)

D (Avt02 Unbranded 39)
FDA Label Image

1 (Avt02 Unbranded 4)

1 (Avt02 Unbranded 4)
FDA Label Image

E (Avt02 Unbranded 40)

E (Avt02 Unbranded 40)
FDA Label Image

F (Avt02 Unbranded 41)

F (Avt02 Unbranded 41)
FDA Label Image

G (Avt02 Unbranded 42)

G (Avt02 Unbranded 42)
FDA Label Image

H (Avt02 Unbranded 43)

H (Avt02 Unbranded 43)
FDA Label Image

I (Avt02 Unbranded 44)

I (Avt02 Unbranded 44)
FDA Label Image

J (Avt02 Unbranded 45)

J (Avt02 Unbranded 45)
FDA Label Image

K (Avt02 Unbranded 46)

K (Avt02 Unbranded 46)
FDA Label Image

L (Avt02 Unbranded 47)

L (Avt02 Unbranded 47)
FDA Label Image

Calendar (Avt02 Unbranded 48)

Calendar (Avt02 Unbranded 48)
FDA Label Image

80 mg Ai Carton (Avt02 Unbranded 49)

80 mg Ai Carton (Avt02 Unbranded 49)
FDA Label Image

Ai 40 mg (Avt02 Unbranded 5)

Ai 40 mg (Avt02 Unbranded 5)
FDA Label Image

1 (Avt02 Unbranded 50)

1 (Avt02 Unbranded 50)
FDA Label Image

2 (Avt02 Unbranded 51)

2 (Avt02 Unbranded 51)
This is a product label for a medication called Simlandi, specifically for adalimumab. It is an injection pre-filled with 20 mg per 0.2 mL for subcutaneous use only. The package includes 2 single-dose pre-filled syringes. The product code is NOC 51759386.*
FDA Label Image

3 (Avt02 Unbranded 52)

3 (Avt02 Unbranded 52)
FDA Label Image

4 (Avt02 Unbranded 53)

4 (Avt02 Unbranded 53)
This text appears to be a description of a medication packaging for a product called Simlandi, which contains adalimumab. The medication is in the form of an injection with a strength of 80 mg/0.8 mL for subcutaneous use only. The packaging includes a single-dose prefilled syringe along with additional items like alcohol preps, a quick reference guide, instructions for use, a medication guide, and prescribing information. The recommended dosage information may also be available.*
FDA Label Image

1 (Avt02 Unbranded 6)

1 (Avt02 Unbranded 6)
FDA Label Image

1 (Avt02 Unbranded 7)

1 (Avt02 Unbranded 7)
FDA Label Image

Figure C (Avt02 Unbranded 8)

Figure C (Avt02 Unbranded 8)
FDA Label Image

Figure D (Avt02 Unbranded 9)

Figure D (Avt02 Unbranded 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.